Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06468202 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

Study acronym: ASPIRIN
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site details revised at 4 of 16 sitesv8
  2. Site contacts updated at 1 of 16 sitesv7
  3. Study sites: 12 to 16v6
  4. Site details revised at 2 of 12 sitesv5
  5. Study sites revised (12)v4
Show 2 earlier versionsHide 2 earlier versions
  1. Study sites: 11 to 12
    • Eligibility criteria shortened, about 14 words
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 1, 2024 to Oct 18, 2024
    • Site details revised at 11 of 11 sites
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The overall goal of this large, pragmatic, comparative effectiveness trial is to test the hypothesis that among at-risk individuals, 162 mg/day aspirin is superior to 81 mg/day in preventing Hypertensive disorders of pregnancy (HDP), and that there are multiple factors associated with adherence with aspirin therapy that will be important to identify to enable optimal implementation of study findings and population-level benefits.
Trial Details
NCT Number NCT06468202
Lead Sponsor Ohio State University
Collaborators: Patient-Centered Outcomes Research Institute, Northwestern University, Preeclampsia Foundation
Conditions
(from sponsor)		 Hypertensive Disorders of Pregnancy, Preeclampsia, Gestational Hypertension
Related terms Hypertension, Pregnancy-Induced, Pre-Eclampsia
Enrollment 10,742 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov